Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and Activated Protein C Resistance

medroxyprogesterone acetate has been researched along with Activated Protein C Resistance in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duschek, EJ; Neele, SJ; Netelenbos, C; Rosing, J; Thomassen, MC1
Ayhan, A; Baykal, C; Demirol, A; Kirazli, S1

Trials

2 trial(s) available for medroxyprogesterone acetate and Activated Protein C Resistance

ArticleYear
Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:8

    Topics: Activated Protein C Resistance; Aged; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Factor V; Female; Homocysteine; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Raloxifene Hydrochloride

2004
Effects of hormone replacement on hemostasis in spontaneous menopause.
    Menopause (New York, N.Y.), 2001,Summer, Volume: 8, Issue:2

    Topics: Activated Protein C Resistance; Adult; Antithrombin III; Blood Coagulation Factors; Double-Blind Method; Estrogen Replacement Therapy; Factor IX; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Partial Thromboplastin Time; Placebos; Prothrombin Time

2001